190 related articles for article (PubMed ID: 36563680)
21. Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.
Zhang Y; Sun Y; Xu Z; Chi P; Lu X
Eur J Surg Oncol; 2017 Aug; 43(8):1440-1446. PubMed ID: 28502421
[TBL] [Abstract][Full Text] [Related]
22. Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.
Miyakita H; Sadahiro S; Suzuki T; Chan LF; Ogimi T; Okada K; Yamamoto S; Kajiwara H
Oncology; 2020; 98(12):869-875. PubMed ID: 32799200
[TBL] [Abstract][Full Text] [Related]
23. Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Huang X; Chen C; Xie W; Zhou C; Tian X; Zhang Z; Wang Q; Chang H; Xiao W; Zhang R; Gao Y
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1255-1269. PubMed ID: 37433373
[TBL] [Abstract][Full Text] [Related]
24. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
25. Predictive value of changes in the level of carbohydrate antigen 19-9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Zheng Z; Wang X; Huang Y; Lu X; Chi P
Colorectal Dis; 2020 Dec; 22(12):2068-2077. PubMed ID: 32936987
[TBL] [Abstract][Full Text] [Related]
26. Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer.
Jia H; Shen X; Guan Y; Xu M; Tu J; Mo M; Xie L; Yuan J; Zhang Z; Cai S; Zhu J; Zhu Z
Radiother Oncol; 2018 Sep; 128(3):548-556. PubMed ID: 30041962
[TBL] [Abstract][Full Text] [Related]
27. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.
Zhu K; Zhao Q; Yue J; Shi P; Yan H; Xu X; Wang R
Oncotarget; 2016 Oct; 7(42):68328-68338. PubMed ID: 27634904
[TBL] [Abstract][Full Text] [Related]
28. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
29. An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma.
Qian L; Lai X; Gu B; Sun X
Front Immunol; 2022; 13():784479. PubMed ID: 35603163
[TBL] [Abstract][Full Text] [Related]
30. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
31. Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis.
Tochigi T; Kamran SC; Parakh A; Noda Y; Ganeshan B; Blaszkowsky LS; Ryan DP; Allen JN; Berger DL; Wo JY; Hong TS; Kambadakone A
Eur Radiol; 2022 Apr; 32(4):2426-2436. PubMed ID: 34643781
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
[No Abstract] [Full Text] [Related]
33. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R
Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063
[TBL] [Abstract][Full Text] [Related]
34. Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer.
Wang H; Jia H; Gao Y; Zhang H; Fan J; Zhang L; Ren F; Yin Y; Cai Y; Zhu J; Zhu ZJ
Nat Commun; 2022 Dec; 13(1):7802. PubMed ID: 36528604
[TBL] [Abstract][Full Text] [Related]
35. Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer.
Jacobs L; van der Vlies E; Ten Bokkel Huinink D; Bloemendal H; Intven M; Smits AB; Weusten BLAM; Siersema PD; van Lelyveld N; Los M
Clin Colorectal Cancer; 2018 Sep; 17(3):179-186. PubMed ID: 29661620
[TBL] [Abstract][Full Text] [Related]
36. [Advances in the prediction of the efficacy and sensitivity of neoadjuvant chemoradiotherapy in rectal cancer].
Ji Q; Li YF; Wu T
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):392-397. PubMed ID: 31054555
[TBL] [Abstract][Full Text] [Related]
37. Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Wang J; Liu J; Wang J; Wang S; Li F; Li R; Liu P; Li M; Wang C
Cancer Cell Int; 2022 Mar; 22(1):117. PubMed ID: 35292026
[TBL] [Abstract][Full Text] [Related]
38. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.
He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB
Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
40. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
